José A. Galván
José A. Galván
Verified email at pathology.unibe.ch
Title
Cited by
Cited by
Year
Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in …
JA Galván, I Zlobec, M Wartenberg, A Lugli, B Gloor, A Perren, ...
British journal of cancer 112 (12), 1944-1950, 2015
1052015
Epithelial–mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor
A López-Soto, L Huergo-Zapico, JA Galván, L Rodrigo, AG de Herreros, ...
The Journal of Immunology 190 (8), 4408-4419, 2013
692013
Synaptic proximity enables NMDAR signalling to promote brain metastasis
Q Zeng, IP Michael, P Zhang, S Saghafinia, G Knott, W Jiao, BD McCabe, ...
Nature 573 (7775), 526-531, 2019
532019
Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer
AM Schläfli, O Adams, JA Galván, M Gugger, S Savic, L Bubendorf, ...
Oncotarget 7 (26), 39544, 2016
532016
TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer
JA Galván, M Helbling, VH Koelzer, MP Tschan, MD Berger, M Hädrich, ...
Oncotarget 6 (2), 874, 2015
532015
COL11A1/(pro) collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression
F Vázquez-Villa, M García-Ocańa, JA Galván, J García-Martínez, ...
Tumor Biology 36 (4), 2213-2222, 2015
482015
CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival
VH Koelzer, A Lugli, H Dawson, M Hädrich, MD Berger, M Borner, ...
Journal of translational medicine 12 (1), 81, 2014
482014
Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high‐level CpG Island methylator phenotype and mismatch repair‐deficiency
H Dawson, JA Galván, M Helbling, DE Muller, E Karamitopoulou, ...
International journal of cancer 134 (10), 2342-2351, 2014
472014
Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome
N Marti, JA Galván, AV Pandey, M Trippel, C Tapia, M Müller, A Perren, ...
Molecular and cellular endocrinology 441, 116-123, 2017
422017
Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer
C García-Pravia, JA Galván, N Gutiérrez-Corral, L Solar-García, ...
PLoS One 8 (10), e78327, 2013
382013
Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors
JA Galván, A Astudillo, A Vallina, G Crespo, MV Folgueras, MV González
BMC cancer 14 (1), 855, 2014
312014
Epithelial-mesenchymal transition markers in the differential diagnosis of gastroenteropancreatic neuroendocrine tumors
JA Galván, A Astudillo, A Vallina, PJ Fonseca, L Gómez-Izquierdo, ...
American journal of clinical pathology 140 (1), 61-72, 2013
302013
Proper paraffin slide storage is crucial for translational research projects involving immunohistochemistry stains
M Economou, L Schöni, C Hammer, JA Galván, DE Mueller, I Zlobec
Clinical and translational medicine 3 (1), 1-3, 2014
272014
Defective autophagy impairs ATF3 activity and worsens lung injury during endotoxemia
A Aguirre, I López-Alonso, A González-López, L Amado-Rodríguez, ...
Journal of molecular medicine 92 (6), 665-676, 2014
252014
Validation of COL11A1/procollagen 11A1 expression in TGF-β1-activated immortalised human mesenchymal cells and in stromal cells of human colon adenocarcinoma
JA Galván, J García-Martínez, F Vázquez-Villa, M García-Ocańa, ...
BMC cancer 14 (1), 867, 2014
202014
Prolonged clinical benefit of everolimus therapy in the management of high-grade pancreatic neuroendocrine carcinoma
PJ Fonseca, E Uriol, JA Galván, C Álvarez, Q Pérez, N Villanueva, ...
Case reports in oncology 6 (2), 441-449, 2013
202013
A multiscale map of the stem cell state in pancreatic adenocarcinoma
NK Lytle, LP Ferguson, N Rajbhandari, K Gilroy, RG Fox, A Deshpande, ...
Cell 177 (3), 572-586. e22, 2019
192019
GKAP acts as a genetic modulator of NMDAR signaling to govern invasive tumor growth
L Li, Q Zeng, A Bhutkar, JA Galván, E Karamitopoulou, D Noordermeer, ...
Cancer cell 33 (4), 736-751. e5, 2018
192018
Immunohistochemical detection of the autophagy markers LC3 and p62/SQSTM1 in formalin-fixed and paraffin-embedded tissue
S Berezowska, JA Galván
Histochemistry of Single Molecules, 189-194, 2017
192017
VE1 immunohistochemistry predicts BRAF V600E mutation status and clinical outcome in colorectal cancer
C Schafroth, JA Galván, I Centeno, VH Koelzer, HE Dawson, L Sokol, ...
Oncotarget 6 (39), 41453, 2015
192015
The system can't perform the operation now. Try again later.
Articles 1–20